A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).

Central Diabetes Insipidus Clinical Trial

Official title:
Peroral Administration of Different Doses of Desmopressin Administered as a New Orally-Disintegrating Tablet and Desmopressin for Nasal Administration in the Treatment of CDI in Japanese Patients

Status Completed

Clinical Trial Summary

This is an open-label dose-titration study in Japanese Central Diabetes Insipidus (CDI) patients designed to demonstrate the efficacy and safety of orally-disintegrating tablet of desmopressin.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01280188
Study type	Interventional
Source	Ferring Pharmaceuticals
Contact
Status	Completed
Phase	Phase 3
Start date	January 2011
Completion date	August 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04897802` - Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)	Phase 4
Recruiting	`NCT03474601` - Seoul National University Pituitary Disease Cohort Study
Not yet recruiting	`NCT04789148` - Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus	Phase 1
Completed	`NCT04902235` - Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)	Phase 4
Completed	`NCT05319301` - Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)	N/A